GL Capital, founded in 2010 by former Country President for Novartis China, Jeffrey Li, is China's leading value investor specialised in the Healthcare sector. The firm focuses on buyout and significant minority opportunities in Healthcare. As of December 2021, GL's total AUM exceeds $2.7B (RMB 18 billion) and has invested in more 60 healthcare companies, with footprint covering the whole healthcare value chain.